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Abstract:  Cutaneous  transilluminators  are  light-emitting  devices  used  to 
localize blood vessels for various medical procedures. They are often used 
in populations that may be at increased risk for skin burns, such as neonates 
and the elderly. While there is a known potential for skin burns, little is 
known about the ophthalmic risk from the use of these devices. This paper 
will report on the laboratory evaluation of the potential ocular hazards from 
transilluminators  (TIs).  Our  results  indicate  that  transilluminators  which 
incorporate  white-light  LEDs  have  emissions  that  have  the  potential  for 
producing  injury  to  the  retina,  especially  in  patients  who  may  have  a 
reduced aversion response. 
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1. Introduction 
Transillumination  with  visible  light  has  been  used  for  many  years  to  provide  enhanced 
visualization of subsurface biological structures, including arteries in the foot, hands or wrists 
of  neonates  for  injections,  blood  draws  and  intravenous  catheter  placement  [1].  It  is  a 
particularly useful technique for venous cannulation in infants with darkly pigmented skin [2]. 
First-generation systems were typically based on high-intensity, AC-powered (e.g., halogen) 
broadband lamps, which delivered light to the skin via fiberoptic probes. An early problem 
from the use of these transilluminators (TIs) during cannulation procedures was temperature 
rise leading to thermal injury and erythema caused by prolonged skin contact [3]. The source 
of these burns has typically been identified as excessive levels of fiberoptically-delivered light 
[4]. 
In recent years there has been a trend towards increasing use of battery-powered TIs that 
incorporate light-emitting diodes (LEDs) [5,6], in part to reduce optical-thermal emissions. As 
LEDs become more efficient and less expensive, they are becoming more commonly used in 
devices such as TIs. In 2007, there was a manufacturer recall due to “excessive heating” from 
these presumably ‘cooler’  LED devices [“Recall of Neonatal Transilluminator Complete,” 
Biomedical  Safety  and  Standards,  Jan  15,  2007].  Although  this  recall  was  due  to  a 
manufacturing error, it highlights the potential hazard of these devices, especially given the 
fact  that  advancements  in  LED  technology  have  enabled  the  generation  of  shorter 
wavelengths of light at higher intensities. In a recent study, we reported on the photothermal 
safety  of  LED-based  transilluminators  in  skin  [7].  This  work  illustrated  that  temperature 
generation by current clinical devices can be significant, although not likely hazardous under 
normal  use  conditions.  In  addition  to  the  potential  for  photothermal  injury  in  skin,  these 
devices  represent  a  potential  ophthalmic  hazard.  However,  there  is  minimal  published 
scientific data regarding the optical output of TIs. It has been known for many years that 
visible  light  (400  to  770  nm)  can  cause  damage  to  the  eye,  especially  at  the  shorter 
wavelength end of the spectrum [8]. Intense optical radiation can cause thermal injury and 
intense visible light can cause photochemical damage to the retina. In fact, visible light can 
produce photic damage even at low intensity if the exposure duration is long enough. This is 
due to the fact that photochemical damage follows the law of reciprocity, i.e. the damage 
depends on the total dose, regardless of whether it is delivered over a short or long time 
duration [9]. Therefore, the purpose of this study was to evaluate the potential for ocular 
damage  from  optical  radiation  emitted  by  TIs  and  to  develop  experimental  methods  for 
quantitative assessment of possible eye injury from these and similar devices. 
2. Methods 
Measurements were performed on six TIs, labeled as TI1 through TI6 to evaluate the potential 
for ophthalmic injury. As summarized in Table 1, TI1 and TI2 contained both white and red 
LEDs, whereas the remaining four devices contained red and/or orange LEDs. 
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Label  LED colors 
TI1  Red and White 
TI2  Red and White 
TI3  Red 
TI4  Orange and Red 
TI5  Orange and Red 
TI6  Orange and Red 
Although  there  are  no  published  safety  limits  for  optical  radiation  that  apply  to  this 
specific type of device, existing standards for general illumination sources can be used to 
provide an estimate of the hazard. The methods used are based on standard test methods 
published jointly by the American National Standards Institute (ANSI) and the Illuminating 
Engineering  Society  of  North  America  (IESNA)  in  their  ANSI/IESNA  Recommended 
Practice RP 27 series of documents [10]. The limit values used in these documents are based 
on those published by the American Conference of Governmental and Industrial Hygienists 
(ACGIH) [11] and are also available in the ICNIRP document on exposure limits to broad-
band incoherent optical radiation [9]. 
Two different optical parameters  were determined for each TI: spectral irradiance and 
spectral radiance. 
2.1 Spectral irradiance 
The spectral irradiance is simply the power per unit area, per unit wavelength, incident on a 
surface and is measured in W/(cm2*nm) (Fig. 1). This quantity is dependent on the distance 
from the source. 
 
Fig. 1. Irradiance. 
The spectral irradiance of all the devices was measured to determine the relative spectral 
output.  Spectral  irradiance  was  measured  with  a  double  grating  spectroradiometer  system 
(Model OL 754, Optronic Laboratories, Orlando, FL). Measurements  were taken at 5 nm 
intervals (instrument bandwidth was 5 nm with a wavelength accuracy of +/− 0.2 nm). The 
input of the spectroradiometer was a 15.24 cm diameter integrating sphere with a 7.92 cm
2 
aperture. The spectroradiometer system was calibrated by measuring the output of a quartz 
halogen standard lamp, traceable to primary standards maintained by the National Institute of 
Standards and Technology. Each TI was mounted approximately 10 cm from the input of the 
integrating  sphere  so  that  the  sphere  collected  the  emitted  radiation  from  all  LEDs 
simultaneously. The beam pattern overfilled the aperture of the sphere in all cases. For this 
measurement it was not necessary to collect all of the emitted radiation, since the desired 
result  was  simply  to  obtain  the  relative  spectral  irradiance  vs  wavelength.  Each  TI  was 
measured over the wavelength range of 380 - 800 nm. Note that these measurements did not 
#129417 - $15.00 USD Received 2 Jun 2010; revised 2 Aug 2010; accepted 31 Aug 2010; published 2 Sep 2010
(C) 2010 OSA 1 October 2010 / Vol. 1,  No. 3 / BIOMEDICAL OPTICS EXPRESS  773simulate actual use conditions, as they were performed at a distance of 10 cm from each 
device. For these measurements, the TIs were operated on battery power. 
2.2 Spectral radiance 
The  spectral  radiance,  which  can  be  used  to  describe  the  brightness  of  a  source,  is  a 
characteristic of the radiating source and is equal to the power emitted from a source per unit 
area, per unit wavelength, and per unit solid angle. It does not change with distance from the 
source (as does irradiance). The solid angle is measured in units of steradians (sr) and spectral 
radiance is measured in units of W/(cm
2*nm*sr) (Fig. 2). 
 
Fig. 2. Radiance. 
Radiance is a useful quantity for evaluating retinal hazards since the radiance of the source 
is directly proportional to the retinal irradiance and known thresholds for damage. For this 
reason, the measured radiance was used to evaluate the potential retinal hazards associated 
with the TIs. 
The spectral radiance from all devices containing white LEDs was measured and from one 
device containing red and/or orange LEDs. Spectral radiance was determined with the use of 
the OL 754 double grating spectroradiometer system and a specialized optical setup (Fig. 3). 
 
Fig. 3. Set-up used for measurement of spectral radiance distribution. 
Radiance (L) was determined using the following equation: 
 
2 z
L
A a
Φ−
=
−
   (1) 
where z is the distance between two apertures, Φ is the spectral radiant power, a is the area of 
the first aperture and A is the area of the second aperture [12]. The spectral radiant power was 
measured with the use of the OL 754 as further described below. All but one LED of each TI 
was masked to ensure that no stray light from the surrounding LEDs was included. Thus, the 
data obtained were from a single LED. 
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[10]. This includes the specification that the spectral radiance shall be averaged over an 11 
mrad right circular cone field of view. It also specifies that a limiting aperture diameter of 3 
mm shall be used. However, we have chosen to use a 7 mm diameter aperture for a more 
conservative evaluation which takes into account that the eyes of premature infants may be 
dilated from an ophthalmic examination [13]. In addition, a conservative user distance of 10 
cm was used for the measurements to account for an accommodation distance of 10 cm for 
persons with high myopia. This is normally the closest distance at which the human eye can 
focus upon a small object [14]. 
Since the radiating surface in an LED is behind a plastic dome, the optical imaging set-up 
shown in Fig. 3 was used [15]. The LED contained two hot spots located at opposite ends, 
approximately ¼ of the diameter from center. In this set-up a 20 Diopter lens is used to form a 
one-to-one image of the LED hot spot at a lens-to-LED distance of 10 cm. Thus the image is 
produced at a distance of 10 cm from the lens. The 7 mm diameter aperture is placed at the 
front surface of the lens and the second aperture that is used to define the field of view is 
located in the image plane of the LED. In this case, a 1.1 mm diameter aperture is used to 
establish the 11 mrad field of view specified by ANSI/IESNA RP 27.1. The input of the 
integrating sphere  was positioned so that the sphere collected all of the emitted radiation 
which passed through the 7 mm and 1.1 mm diameter apertures. The spectral radiant power, Φ 
that is used in Eq. (1) is calculated by multiplying the value obtained by the spectroradiometer 
by the area of the entrance aperture of the integrating sphere. Each device was measured over 
a wavelength range of 380 - 800 nm and operated from a regulated D.C. power supply (Model 
E3648A, Agilent Technologies, Inc., Santa Clara, CA) set at 4.5 volts. 
In order to determine the output stability of each TI diode, the TIs were oriented with 
respect to the optical set-up to maximize the reading obtained using a broad-band detector 
connected to a power meter (Model 350 Optometer, Graseby Optronics, Orlando, FL). Testing 
showed that under these conditions, the output of the brightest white LED in TI1 was constant 
to  within  1%  over  a  90  min  time  period.  This  set-up  was  also  used  to  determine  the 
differences between LED output. 
2.3 Hazard analysis 
Wavelengths in the 400 - 1400 nm region are of particular concern for retinal injury. Those 
wavelengths near 440 nm (blue) have been shown to be the most hazardous to the retina [16]. 
Two light hazard functions for photochemical injury are included in the RP 27.1 limits, shown 
in Fig. 4. They are applicable to a wavelength range of 300 - 700 nm. One is the blue light 
hazard function, and the other is the aphakic hazard function. The difference between these 
two hazard functions is that the blue light hazard function is intended for use in normal adult 
eyes with an intact natural lens, while the aphakic function is intended to be used in the case 
where the natural lens in the eye has been removed. The aphakic hazard function was used for 
a worst case scenario in this study since infants have higher transmission of UV and visible 
light through their lens [17] and, in fact, ICNIRP recommends that this weighting function be 
used for children < 2 yrs old [9]. 
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Fig. 4. ANSI/IESNA Blue Light & Aphakic Hazard Functions. 
The  source  spectral  radiance  was  calculated  using  Eq.  (1)  and  the  measurements  of 
spectral radiant power. The spectral radiance calculations were weighted by the aphakic light 
hazard function and integrated over 380 - 700 nm to obtain the aphakic-weighted radiance of 
the  source.  The  ANSI/IESNA  RP  27.1  photochemical  retinal  hazard  limit  for  integrated 
spectral radiance weighted by the aphakic light hazard function is 100 J/(cm
2-sr) for exposure 
times <10,000 seconds. This limit is defined as the threshold limit value (TLV). An exposure 
time to reach this limit, Time  TLV, can be calculated by dividing the exposure limit by the 
aphakic-weighted retinal radiance, LA, 
  TLV A Time  100/ L . =    (2) 
TI1  and  TI2  devices  were  the  focus  of  the  evaluation  for  retinal  injury,  since  these 
contained the white light LEDs. We also evaluated a total of 3 of the TI1 devices, purchased 
at different times to measure the variability between devices. [For this relative comparison, 
spectral power was not measured, only total power using the Graseby Optronics meter].The 
other devices (TI3 – TI6) containing only red and/or orange LEDs were deemed to be far less 
hazardous due to the relatively low effectiveness for photochemical retinal damage in this 
wavelength region. However, one measurement of a red and an orange LED was made to 
confirm this. 
ANSI/IESNA RP 27.1 also specifies a retinal thermal hazard limit that is applicable for 
periods of time from 1  s to 10 s. The thermal hazard weighting function is defined over the 
380 to 1400 nm wavelength range, but is equal to a value of 1.0 over most of the visible 
wavelength range. We compared the integrated spectral radiance from 380 to 800 nm to the 
thermal hazard limit of 5/αt
1/4, where α is the angular subtense of the source in radians, which 
we calculated to be 50 mrads at a distance of 10 cm, and t is the exposure time. Measurements 
at  wavelengths  greater  than  800  nm  were  not  needed  since  we  determined  there  was  no 
significant measureable output from any TI at wavelengths greater than 750 nm. 
3. Results 
3.1 Spectral irradiance 
Figure 5 shows plots of spectral irradiance and aphakic weighted spectral irradiance for TI2 
which  included  both  red  and  white  LEDs.  Figure  6  shows  the  same  plots  for  TI5 which 
included red and orange LEDs. For TI2, the white LEDs had a narrow band of emission 
centered at 465 nm (bandwidth (BW) ca. 30 nm) and a broad band of emission centered at 560 
nm (BW ca. 200 nm). Interestingly, one of the 4 white LEDs in one of the two TI2 devices 
that were evaluated had a peak emission at 440 nm, instead of 465 nm. For TI1 (spectra not 
shown) 3 out of 5 of the white LEDs evaluated had a peak emission at 440 nm, instead of 465 
nm. Also, for TI2, the red LEDs had a narrow band of emission centered at 645 nm (BW ca. 
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Fig. 5. Graph of the relative spectral irradiance and aphakic weighted spectral irradiance versus 
wavelength for TI2, which contains red and white LEDs, on a semi-logarithmic plot. 
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Fig.  6.  Graph  of  the  spectral  irradiance  and  aphakic  weighted  spectral  irradiance  versus 
wavelength for TI5, which contains red and orange LEDs. 
3.2 Spectral radiance 
Visually, the LED appeared to have a non-uniform radiating pattern with two clearly defined 
hot spots on opposite sides of the LED. Measurements were made by carefully locating the 
1.1 mm diameter aperture over the hot spot that produced the highest reading using the power 
meter. 
The  spectral  radiance  was  weighted  with  the  aphakic  action  spectrum,  integrated  and 
compared to the Time TLV. The mean time to reach the TLV for all the white light LEDs tested 
was 4.0 minutes, with a std. dev of 1.45 minutes. The range of results for individual white 
LEDs ranged from 2.06 – 6.7 minutes. Since the output of the LEDs was very stable when 
operating  with  the  regulated  power  supply,  it  appears  that  the  large  standard  deviation 
observed is primarily due to (1) our ability to locate the 1.1 mm diameter aperture at the exact 
same position over the hot spot and (2) variation in output from LED to LED. We measured a 
total of 4 white LEDs in 3 of the TI1 devices and found that there was a large variation (29 – 
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white light LEDs within the same instrument as shown in Table 2. 
Table 2. Variation in relative radiance for 4 different white LEDs for device type TI1. 
Data for three different devices and two LED positions are presented 
Device #  1  2  2  3 
LED Position  1  1  2  1 
Mean Relative 
Irradiance 
(mW/cm
2) 
110.0 ± 4.6  69.8 ± 2.2  74.7 ± 4.5  78.0 ± 2.0 
It  can  be  shown  that  if  two  light  sources  are  less  than  0.1  radians  apart,  the  optical 
radiation  from  the  sources  can  overlap  on  the  same  area  on  the  retina  [18].  Since  the 
separation of the white diodes in each TI is less than 0.1 radians at a distance of 10 cm, the 
output from the two diodes was added together. This results in a range of times to reach the 
ANSI/IESNA RP 27.1 limit to between 1.03 and 3.35 minutes. 
The calculated time to reach the RP 27.1 photochemical retinal hazard limit for the red 
diode was over 1000 minutes, while for one of the orange diodes, it was over 5000 minutes. It 
was, therefore, not deemed  necessary to  measure  the radiance of the other red or orange 
diodes  as  the  retinal  hazard  weighting  factor  is  so  heavily  weighted  in  the  blue  region 
compared to the red and orange region. Since one red and one orange LED were calculated to 
have a large time to reach the limit, it can be safely assumed that the others would also have a 
large time as well and therefore do not pose a retinal photochemical hazard. 
ANSI/IESNA RP 27.1 also specifies a retinal thermal hazard limit that is applicable for 
periods of time from 1 s to 10 s. The thermal weighted radiance limit is 56.5 W/(cm
2-sr) for 
10 s. The thermal weighted radiance found for the white light LEDs ranged from 0.64 to 1.24 
W/(cm
2-sr). Thus, the mean thermal weighted radiance ranged from 45 to 69 times below the 
limit for 10 s. Therefore, the white light LEDs for the devices tested do not pose a retinal 
thermal hazard. The red LEDs fell within the same range and the orange LED had an even 
lower thermal weighted radiance or 0.15 W/(cm
2-sr). Therefore, they also are not expected to 
pose a retinal thermal hazard. 
4. Discussion and conclusions 
In  a  recent  study,  our  group  found  that  TIs  have  the  potential  to  induce  a  significant 
temperature rise in skin, yet they do not represent a significant safety concern for exposure 
durations of  four  minutes or less [7]. Our current research provides quantitative evidence 
regarding the potential for optical radiation –induced retinal damage, with a particular focus 
on  the  short  visible  wavelengths  (i.e.,  blue  light)  known  to  be  the  most  hazardous. 
Transilluminators  used  to  locate  blood  vessels  have  traditionally  used  white  light  from  a 
halogen lamp, but more recent devices are available which use red, orange or white LEDs. We 
evaluated  several  different  models  of  transilluminators;  two  of  which  used  white  and  red 
LEDs, one that used red LEDs and three that used red and orange LEDs. Although we were 
most concerned with white LED devices due to their strong emissions at blue wavelengths, we 
also evaluated the times to reach the safety limit for the red and orange LEDs. As expected, 
these longer wavelength LEDs represent a much lower potential hazard for retinal damage. 
Based  on  our  evaluation,  the  light  levels  produced  by  all  the  TIs  were  below  the 
acceptable limits relevant to eye safety. However, the Time TLV is sufficiently short for TI1 
and TI2 (1.03-3.35 minutes) that caution is needed to avoid ocular exposure. This is probably 
not a significant risk for healthy adults, since most individuals utilizing these devices will not 
be looking directly at the diode emissions for any length of time. However, it may be a risk 
for neonates who may be more sensitive and may lack a developed aversion response to bright 
light  [19].  Also,  Mactier  et  al  showed  that  the  eyes  of  infants  age  40-50  weeks  (post-
menstrual) are significantly smaller than adult eyes [20]. They estimate that given a constant 
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young infant eye. However, their results were based on measurements of vitreous chamber 
depth, which does not take into account the focusing properties of the eye, which may be less 
efficient in the very young eye. In the worst case scenario – i.e. if the young eye has the 
ability to focus images to a sharp spot on the retina – the resulting Time TLV would range from 
21 seconds to 1.1 minutes. An additional consideration is that increased oxygen levels in the 
blood will reduce the dose needed to produce damage in the retina. Since some neonates are 
kept in an enhanced-oxygen environment, this may put them at a higher risk [21]. 
It is interesting to note that the “white light” diode has peak irradiance in the region of 440 
nm or 460 nm, which is in the blue region of the spectrum – the wavelength region to which 
the retina is most sensitive. It should be noted that the investigators of this study found it quite 
uncomfortable to look at the white LEDs, even for a brief moment of time. Recently, Morgan 
et al [22] demonstrated that exposures below the published safety standards for 568 nm light 
were capable of producing retinal damage. An analysis of the hazard from this wavelength 
region should be evaluated once appropriate weighting factors have been developed. There is 
also the question of whether white light is actually necessary for effective transillumination, 
as the devices that use only red or orange LEDs seem to perform their intended function quite 
well [23]. 
We applied the measurement principles from ANSI/IESNA RP 27.1 in this evaluation, 
which is similar to the method used by Halbritter et al [24]. Problems identified with using 
this method include lack of reproducibility among untrained staff and difficulties in aligning 
the  hot  spot  with  the  1.1  mm  diameter  aperture.  Instruments  that  can  easily  and  quickly 
measure radiance directly from such sources as the LEDs encountered here would be highly 
desirable. 
Given the low cost and increasing popularity of white light LEDs, combined with their 
increasing  power  levels  and  shorter  emission  wavelengths,  it  is  likely  that  the  need  for 
appropriate techniques for assessing ocular safety hazards in these devices will increase in the 
future. Four of the six transilluminators measured in this study – those incorporating red and 
orange LEDs only – do not appear to present a significant eye hazard. Two of the six TIs – the 
TI1 and TI2, which incorporate white light LEDs, reached the retinal exposure limit in only 
1.03-3.35 minutes. This raises the question about potential exposure hazards to the eyes of 
neonates, which may be more sensitive and may lack a developed aversion response to bright 
light. Therefore caregivers should avoid shining the bright light of the TIs at the eyes of 
neonates, infants and children, or any patient who may have a reduced aversion response. We 
should emphasize that the values obtained are based upon the use of conservative values for 
the measurements to err on the side of safety. Nonetheless, to minimize the risk of future eye 
and skin injuries, the development of an international consensus standard for these devices 
should also be considered. 
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